IDH1 and glioma: Thus, those patients with gliomas exhibiting NSUN5 epigenetic silencing, like those carrying IDH1 mutations, have tumor cells that probably are on the verge of death, whose last resort in their struggle to survive is to restrict overall protein synthesis and to instigate particular emergency translational programs to deal with multiple stress conditions.